Speakers

Anthony L. Back, MD

Professor of Oncology

University of Washington, Seattle

Dr. Back presents findings from a study of anxiety and depression in patients with metastatic and incurable cancers using a group dosage session protocol within a retreat environment.

Kevin Balktick

Horizons Media, Inc.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Myriam Barthes

CEO and Co-Founder

Journey Clinical

Myriam Barthes explains how independent therapists can offer psychedelic-assisted psychotherapy to their patients, with medical support, insurance coverage, education and community.

A.J. Cannon, MD

Medical Director, Neuroscience Clinical Development

AbbVie

Dr. Cannon, a Medical Director managing a CNS portfolio at AbbVie, one of the world’s largest pharmaceutical companies, brings a critical industry perspective to the discussion of psychedelic drug development.

Lori Englebert

Chief Commercial Officer

Compass Pathways

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Gisele Fernandes-Osterhold, LMFT

Director of Psychedelic Facilitation, TrPR Program

University of California San Francisco (UCSF)

Gisele Fernandes-Osterhold presents recent psilocybin study data for Parkinson’s, chronic pain, and others while considering meaning-making, quality of life, and psychological aspects of psychedelic therapy.

Manesh Girn, PhD

University of California, San Francisco

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Jazz Glastra

Senior Director

BrainFutures

Jazz Glastra illuminates the reality and complexity of a post-approval world, where numerous regulatory and insurance challenges may still stand in between approvals and appointments.

Guy Goodwin, MD

Chief Medical Officer

Compass Pathways

University of Oxford, Emeritus Professor of Psychiatry

Dr. Goodwin, one of the most cited researchers in psychiatry, presents the findings of the largest psilocybin treatment trial in the world, and the questions that will inform the next generation of research.

Andrew Gradison, JD

U.S. Department of Veterans Affairs

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Harry Grammer, PhD

Founder

New Earth

Dr. Grammer, who has devoted his life to reforming the juvenile justice system, shares his experiences bringing psychedelic healing to recently-released youth communities in Los Angeles.

Josh Hardman

Psychedelic Alpha

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Rikki Harris

CEO

TN Voices

Rikki Harris shares the story of how a community coalition realized a landmark law to accelerate the research into ibogaine therapy in Tennessee.

Julie Holland, MD

Private practice, New York City

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Bryan Hubbard

CEO

Americans for Ibogaine

In his return to the Horizons stage, Bryan Hubbard tells how ibogaine went from obscurity to the Oval Office, and how state and federal governments can accelerate the next wave of research.

Edny Inui, PhD, MBA

Partner

Palo Santo

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Bia Labate, PhD

Executive Director

Chacruna Institute

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Amy Lehrner, PhD

Icahn School of Medicine at Mount Sinai

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Connor Williams

Senior Research Analyst

RTW Investments

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Rachel Yehuda, PhD

Icahn School of Medicine at Mount Sinai

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Matthew Zorn, JD

U.S. Department of Health and Human Services

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.